by Michael Passwater Orthomolecular Medicine News Service OMNS (Feb. 17, 2022) The Harvard led Vitamin D and Omega 3 trial (VITAL), recently published findings showing a meaningful (22%) and statistically significant (p = 0.05, Hazard ratio = 0.78 95% CI = 0.61 - 0.99) reduction in the incidence of autoimmune disease in older adults taking 2000 IU (50 mcg) per day for 5 years. [1] This was a large nationwide study involving 12,786 men 50 years or older and 13,085 women 55 ye